-
1
-
-
0031453534
-
AC133, a novel marker for human hematopoietic stem and progenitor cells
-
Yin AH, Miraglia S, Zanjani ED, et al.: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12. This is the first paper that links AC133, later now named as CD133, to stem cells. (Pubitemid 28007217)
-
(1997)
Blood
, vol.90
, Issue.12
, pp. 5002-5012
-
-
Yin, A.H.1
Miraglia, S.2
Zanjani, E.D.3
Almeida-Porada, G.4
Ogawa, M.5
Leary, A.G.6
Olweus, J.7
Kearney, J.8
Buck, D.W.9
-
2
-
-
0031468289
-
A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning
-
Miraglia S, GodfreyW, YinAH, et al.: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-21. This is the first paper to clone the CD133. (Pubitemid 28007218)
-
(1997)
Blood
, vol.90
, Issue.12
, pp. 5013-5021
-
-
Miraglia, S.1
Godfrey, W.2
Yin, A.H.3
Atkins, K.4
Warnke, R.5
Holden, J.T.6
Bray, R.A.7
Waller, E.K.8
Buck, D.W.9
-
3
-
-
0031019745
-
Isolation of putative progenitor endothelial cells for angiogenesis
-
DOI 10.1126/science.275.5302.964
-
Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-7. (Pubitemid 27087709)
-
(1997)
Science
, vol.275
, Issue.5302
, pp. 964-967
-
-
Asahara, T.1
Murohara, T.2
Sullivan, A.3
Silver, M.4
Van Der Zee, R.5
Li, T.6
Witzenbichler, B.7
Schatteman, G.8
Isner, J.M.9
-
4
-
-
33749005405
-
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors
-
DOI 10.1126/science.1127592
-
Shaked Y, Ciarrocchi A, Franco M, et al.: Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006;313:1785-7. This is the first paper to highlight the importance of endothelial progenitor cells. (Pubitemid 44454154)
-
(2006)
Science
, vol.313
, Issue.5794
, pp. 1785-1787
-
-
Shaked, Y.1
Ciarrocchi, A.2
Franco, M.3
Lee, C.R.4
Man, S.5
Cheung, A.M.6
Hicklin, D.J.7
Chaplin, D.8
Foster, F.S.9
Benezra, R.10
Kerbel, R.S.11
-
5
-
-
33846095137
-
Identification and expansion of human colon-cancer-initiating cells
-
DOI 10.1038/nature05384, PII NATURE05384
-
Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al.: Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-5. This is the first paper to isolate colon cancer stem cells. (Pubitemid 46067311)
-
(2007)
Nature
, vol.445
, Issue.7123
, pp. 111-115
-
-
Ricci-Vitiani, L.1
Lombardi, D.G.2
Pilozzi, E.3
Biffoni, M.4
Todaro, M.5
Peschle, C.6
De Maria, R.7
-
6
-
-
9244241576
-
Identification of human brain tumour initiating cells
-
DOI 10.1038/nature03128
-
Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396-401. (Pubitemid 39551674)
-
(2004)
Nature
, vol.432
, Issue.7015
, pp. 396-401
-
-
Singh, S.K.1
Hawkins, C.2
Clarke, I.D.3
Squire, J.A.4
Bayani, J.5
Hide, T.6
Henkelman, R.M.7
Cusimano, M.D.8
Dirks, P.B.9
-
7
-
-
59049087696
-
Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
-
Zhu L, Gibson P, Currle DS, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature. 2009;457:603-7.
-
(2009)
Nature
, vol.457
, pp. 603-607
-
-
Zhu, L.1
Gibson, P.2
Currle, D.S.3
-
8
-
-
40749150740
-
+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
-
DOI 10.1038/sj.onc.1210811, PII 1210811
-
Ma S, Lee TK, Zheng BJ, et al. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene. 2008;27:1749-58. (Pubitemid 351380265)
-
(2008)
Oncogene
, vol.27
, Issue.12
, pp. 1749-1758
-
-
Ma, S.1
Lee, T.K.2
Zheng, B.-J.3
Chan, K.W.4
Guan, X.-Y.5
-
9
-
-
49949111381
-
Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells
-
Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One. 2008;3:e2637.
-
(2008)
PLoS One
, vol.3
-
-
Chen, Y.C.1
Hsu, H.S.2
Chen, Y.W.3
-
10
-
-
79955632648
-
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
-
Stewart JM, Shaw PA, Gedye C, et al. Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc Natl Acad Sci USA. 2011;108:6468-73.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 6468-6473
-
-
Stewart, J.M.1
Shaw, P.A.2
Gedye, C.3
-
11
-
-
70349479538
-
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
-
Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA. 2009;106:16281-6.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 16281-16286
-
-
Bertolini, G.1
Roz, L.2
Perego, P.3
-
12
-
-
57649140583
-
Generation of a prostate from a single adult stem cell
-
Leong KG, Wang BE, Johnson L, Gao WQ. Generation of a prostate from a single adult stem cell. Nature. 2008;456:804-8.
-
(2008)
Nature
, vol.456
, pp. 804-808
-
-
Leong, K.G.1
Wang, B.E.2
Johnson, L.3
Gao, W.Q.4
-
13
-
-
51649111430
-
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
-
Vermeulen L, Todaro M, de Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA. 2008;105:13427-32.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 13427-13432
-
-
Vermeulen, L.1
Todaro, M.2
De Sousa, M.F.3
-
14
-
-
78650098659
-
Glioblastoma stemlike cells give rise to tumour endothelium
-
This paper links the stem cells to tumor angiogenesis directly via CD133-expressing cells
-
Wang R, Chadalavada K, Wilshire J, et al.: Glioblastoma stemlike cells give rise to tumour endothelium. Nature 2010;468:829-33. This paper links the stem cells to tumor angiogenesis directly via CD133-expressing cells.
-
(2010)
Nature
, vol.468
, pp. 829-833
-
-
Wang, R.1
Chadalavada, K.2
Wilshire, J.3
-
15
-
-
45749102020
-
- metastatic colon cancer cells initiate tumors
-
DOI 10.1172/JCI34401
-
Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest. 2008;118:2111-20. (Pubitemid 351872330)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.6
, pp. 2111-2120
-
-
Shmelkov, S.V.1
Butler, J.M.2
Hooper, A.T.3
Hormigo, A.4
Kushner, J.5
Milde, T.6
St Clair, R.7
Baljevic, M.8
White, I.9
Jin, D.K.10
Chadburn, A.11
Murphy, A.J.12
Valenzuela, D.M.13
Gale, N.W.14
Thurston, G.15
Yancopoulos, G.D.16
D'Angelica, M.17
Kemeny, N.18
Lyden, D.19
Rafii, S.20
more..
-
16
-
-
28244472369
-
Prospective identification of tumorigenic prostate cancer stem cells
-
DOI 10.1158/0008-5472.CAN-05-2018
-
Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946-51. (Pubitemid 41713363)
-
(2005)
Cancer Research
, vol.65
, Issue.23
, pp. 10946-10951
-
-
Collins, A.T.1
Berry, P.A.2
Hyde, C.3
Stower, M.J.4
Maitland, N.J.5
-
17
-
-
33847052127
-
Identification of pancreatic cancer stem cells
-
Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67:1030-7.
-
(2007)
Cancer Res
, vol.67
, pp. 1030-1037
-
-
Li, C.1
Heidt, D.G.2
Dalerba, P.3
-
18
-
-
34547193404
-
Phenotypic characterization of human colorectal cancer stem cells
-
DOI 10.1073/pnas.0703478104
-
Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA. 2007;104:10158-63. (Pubitemid 47175279)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.24
, pp. 10158-10163
-
-
Dalerba, P.1
Dylla, S.J.2
Park, I.-K.3
Liu, R.4
Wang, X.5
Cho, R.W.6
Hoey, T.7
Gurney, A.8
Huang, E.H.9
Simeone, D.M.10
Shelton, A.A.11
Parmiani, G.12
Castelli, C.13
Clarke, M.F.14
-
19
-
-
65949112714
-
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis
-
Huang EH, Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69:3382-9.
-
(2009)
Cancer Res
, vol.69
, pp. 3382-3389
-
-
Huang, E.H.1
Hynes, M.J.2
Zhang, T.3
-
20
-
-
56149088742
-
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene
-
Yin C, Lin Y, Zhang X, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology. 2008;48:1528-39.
-
(2008)
Hepatology.
, vol.48
, pp. 1528-1539
-
-
Yin, C.1
Lin, Y.2
Zhang, X.3
-
21
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
DOI 10.1038/35102167
-
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-11. (Pubitemid 33041634)
-
(2001)
Nature
, vol.414
, Issue.6859
, pp. 105-111
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
Weissman, I.L.4
-
22
-
-
77952502408
-
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth
-
Roesch A, Fukunaga-Kalabis M, Schmidt EC, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 2010;141:583-94.
-
(2010)
Cell
, vol.141
, pp. 583-594
-
-
Roesch, A.1
Fukunaga-Kalabis, M.2
Schmidt, E.C.3
-
23
-
-
73149110562
-
Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content
-
Pece S, Tosoni D, Confalonieri S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 2010;140:62-73.
-
(2010)
Cell
, vol.140
, pp. 62-73
-
-
Pece, S.1
Tosoni, D.2
Confalonieri, S.3
-
25
-
-
79953042645
-
CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule
-
Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11:254-67.
-
(2011)
Nat Rev Cancer.
, vol.11
, pp. 254-267
-
-
Zoller, M.1
-
27
-
-
59249094144
-
CD44 and EpCAM: Cancer-initiating cell markers
-
Marhaba R, Klingbeil P, Nuebel T, et al. CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med. 2008;8:784-804.
-
(2008)
Curr Mol Med.
, vol.8
, pp. 784-804
-
-
Marhaba, R.1
Klingbeil, P.2
Nuebel, T.3
-
28
-
-
0037424235
-
Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins
-
DOI 10.1074/jbc.M210640200
-
Fargeas CA, Florek M, Huttner WB, Corbeil D. Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem. 2003;278:8586-96. (Pubitemid 36800613)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.10
, pp. 8586-8596
-
-
Fargeas, C.A.1
Florek, M.2
Huttner, W.B.3
Corbeil, D.4
-
29
-
-
4944232476
-
Identification of novel prominin-1/CD133 splice variants with altrnative C-termini and their expression in epididymis and testis
-
DOI 10.1242/jcs.01315
-
Fargeas CA, Joester A,Missol-Kolka E, et al. Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci. 2004;117:4301-11. (Pubitemid 39328316)
-
(2004)
Journal of Cell Science
, vol.117
, Issue.18
, pp. 4301-4311
-
-
Fargeas, C.A.1
Joester, A.2
Missol-Kolka, E.3
Hellwig, A.4
Huttner, W.B.5
Corbeil, D.6
-
30
-
-
77951911233
-
The intriguing links between prominin-1 (CD133), cholesterolbased membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation
-
Corbeil D, Marzesco AM, Wilsch-Brauninger M, Huttner WB. The intriguing links between prominin-1 (CD133), cholesterolbased membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett. 2010;584:1659-64.
-
(2010)
FEBS Lett.
, vol.584
, pp. 1659-1664
-
-
Corbeil, D.1
Marzesco, A.M.2
Wilsch-Brauninger, M.3
Huttner, W.B.4
-
31
-
-
0032940090
-
Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells - A combination of apical sorting and retention in plasma membrane protrusions
-
Corbeil D, Roper K, Hannah MJ, et al. Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells - a combination of apical sorting and retention in plasma membrane protrusions. J Cell Sci. 1999;112(Pt 7):1023-33. (Pubitemid 29182172)
-
(1999)
Journal of Cell Science
, vol.112
, Issue.7
, pp. 1023-1033
-
-
Corbeil, D.1
Roper, K.2
Hannah, M.J.3
Hellwig, A.4
Huttner, W.B.5
-
32
-
-
76649089339
-
Microenvironmental modulation of asymmetric cell division in human lung cancer cells
-
This is the first paper to link CD133 to asymmetric division in lung cancer cells
-
Pine SR, Ryan BM, Varticovski L, et al.: Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci USA 2010;107:2195-200. This is the first paper to link CD133 to asymmetric division in lung cancer cells.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 2195-2200
-
-
Pine, S.R.1
Ryan, B.M.2
Varticovski, L.3
-
33
-
-
79951668217
-
Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity
-
Dev Dyn 2011
-
Anderson LH, Boulanger CA, Smith GH, et al.: Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn 2011.
-
The Mammary Gland
-
-
Anderson, L.H.1
Boulanger, C.A.2
Smith, G.H.3
-
34
-
-
45549091414
-
Prostate cancer stem cells: A new target for therapy
-
Maitland NJ, Collins AT. Prostate cancer stem cells: a new target for therapy. J Clin Oncol. 2008;26:2862-70.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 2862-2870
-
-
Maitland, N.J.1
Collins, A.T.2
-
35
-
-
34548455927
-
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
-
DOI 10.1016/j.stem.2007.06.002, PII S1934590907000665
-
Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313-23. (Pubitemid 47355323)
-
(2007)
Cell Stem Cell
, vol.1
, Issue.3
, pp. 313-323
-
-
Hermann, P.C.1
Huber, S.L.2
Herrler, T.3
Aicher, A.4
Ellwart, J.W.5
Guba, M.6
Bruns, C.J.7
Heeschen, C.8
-
36
-
-
54249143589
-
Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, andmelanoma cell lines
-
Jaksch M, Munera J, Bajpai R, et al. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, andmelanoma cell lines. Cancer Res. 2008;68:7882-6.
-
(2008)
Cancer Res.
, vol.68
, pp. 7882-7886
-
-
Jaksch, M.1
Munera, J.2
Bajpai, R.3
-
37
-
-
78650315639
-
CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche
-
Kim M, Koh YJ, Kim KE, et al. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 2010;70:10411-21.
-
(2010)
Cancer Res.
, vol.70
, pp. 10411-10421
-
-
Kim, M.1
Koh, Y.J.2
Kim, K.E.3
-
38
-
-
33846100356
-
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
-
DOI 10.1038/nature05372, PII NATURE05372
-
O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106-10. (Pubitemid 46067310)
-
(2007)
Nature
, vol.445
, Issue.7123
, pp. 106-110
-
-
O'Brien, C.A.1
Pollett, A.2
Gallinger, S.3
Dick, J.E.4
-
39
-
-
79952011719
-
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma
-
Shimada M, Sugimoto K, Iwahashi S, et al. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol. 2010;45:896-902.
-
(2010)
J Gastroenterol.
, vol.45
, pp. 896-902
-
-
Shimada, M.1
Sugimoto, K.2
Iwahashi, S.3
-
40
-
-
51649119918
-
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations
-
Ma S, Chan KW, Lee TK, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res. 2008;6:1146-53.
-
(2008)
Mol Cancer Res.
, vol.6
, pp. 1146-1153
-
-
Ma, S.1
Chan, K.W.2
Lee, T.K.3
-
41
-
-
79957917044
-
Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival
-
Silva IA, Bai S, McLean K, et al.: Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 2011.
-
(2011)
Cancer Res
-
-
Silva, I.A.1
Bai, S.2
McLean, K.3
-
42
-
-
67649359505
-
CD133 and nuclear beta-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
-
Horst D, Kriegl L, Engel J, et al. CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer. 2009;45:2034-40.
-
(2009)
Eur J Cancer.
, vol.45
, pp. 2034-2040
-
-
Horst, D.1
Kriegl, L.2
Engel, J.3
-
43
-
-
70349754442
-
MTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells
-
Matsumoto K, Arao T, Tanaka K, et al. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res. 2009;69:7160-4.
-
(2009)
Cancer Res.
, vol.69
, pp. 7160-7164
-
-
Matsumoto, K.1
Arao, T.2
Tanaka, K.3
-
44
-
-
54249127417
-
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors
-
Yi JM, Tsai HC, Glockner SC, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res. 2008;68:8094-103.
-
(2008)
Cancer Res.
, vol.68
, pp. 8094-8103
-
-
Yi, J.M.1
Tsai, H.C.2
Glockner, S.C.3
-
45
-
-
58249095085
-
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
-
Baba T, Convery PA, Matsumura N, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene. 2009;28:209-18.
-
(2009)
Oncogene.
, vol.28
, pp. 209-218
-
-
Baba, T.1
Convery, P.A.2
Matsumura, N.3
-
46
-
-
78449255989
-
MiR-200a regulates epithelialmesenchymal to stem-like transition via ZEB2 and beta-catenin signaling
-
Xia H, Cheung WK, Sze J, et al. miR-200a regulates epithelialmesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem. 2010;285:36995-7004.
-
(2010)
J Biol Chem.
, vol.285
, pp. 36995-37004
-
-
Xia, H.1
Cheung, W.K.2
Sze, J.3
-
47
-
-
78649681554
-
MiR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1
-
Ma S, Tang KH, Chan YP, et al. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell. 2010;7:694-707.
-
(2010)
Cell Stem Cell.
, vol.7
, pp. 694-707
-
-
Ma, S.1
Tang, K.H.2
Chan, Y.P.3
-
48
-
-
69949087531
-
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells
-
Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 2009;4: e6816.
-
(2009)
PLoS One.
, vol.4
-
-
Ji, Q.1
Hao, X.2
Zhang, M.3
-
49
-
-
79952119592
-
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations
-
This is the first paper to describe a CD133-related gene expression signature in GBM, and these signatures are shared among other tumor types
-
Yan X, Ma L, Yi D, et al.: A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci USA 2011;108:1591-6. This is the first paper to describe a CD133-related gene expression signature in GBM, and these signatures are shared among other tumor types.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 1591-1596
-
-
Yan, X.1
Ma, L.2
Yi, D.3
-
50
-
-
77951192102
-
Stem-like cancer cells are inducible by increasing genomic instability in cancer cells
-
Liang Y, Zhong Z, Huang Y, et al. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem. 2010;285:4931-40.
-
(2010)
J Biol Chem.
, vol.285
, pp. 4931-4940
-
-
Liang, Y.1
Zhong, Z.2
Huang, Y.3
-
51
-
-
68349114796
-
Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
-
Li CY, Li BX, Liang Y, et al. Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med. 2009;7:56.
-
(2009)
J Transl Med.
, vol.7
, pp. 56
-
-
Li, C.Y.1
Li, B.X.2
Liang, Y.3
-
52
-
-
79956309778
-
Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma
-
Xi HQ, Zhao P: Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol 2011.
-
(2011)
J Clin Pathol
-
-
Xi, H.Q.1
Zhao, P.2
-
53
-
-
75449109041
-
Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
-
Prognostic value of CD133 mRNA in colorectal cancer is proposed
-
Artells R, Moreno I, Diaz T, et al.: Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer 2010;46:642-9. Prognostic value of CD133 mRNA in colorectal cancer is proposed.
-
(2010)
Eur J Cancer
, vol.46
, pp. 642-649
-
-
Artells, R.1
Moreno, I.2
Diaz, T.3
-
54
-
-
53849134099
-
CD133 expression is an independent prognostic marker for low survival in colorectal cancer
-
Horst D, Kriegl L, Engel J, et al. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer. 2008;99:1285-9.
-
(2008)
Br J Cancer.
, vol.99
, pp. 1285-1289
-
-
Horst, D.1
Kriegl, L.2
Engel, J.3
-
55
-
-
77955073877
-
Prognostic impact of CD133 expression in gastric carcinoma
-
Ishigami S, Ueno S, Arigami T, et al. Prognostic impact of CD133 expression in gastric carcinoma. Anticancer Res. 2010;30:2453-7.
-
(2010)
Anticancer Res.
, vol.30
, pp. 2453-2457
-
-
Ishigami, S.1
Ueno, S.2
Arigami, T.3
-
56
-
-
80052709582
-
Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: A prospective patient cohort at a single institution
-
Metellus P, Nanni-Metellus I, Delfino C, et al.: Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution. Ann Surg Oncol 2011.
-
(2011)
Ann Surg Oncol
-
-
Metellus, P.1
Nanni-Metellus, I.2
Delfino, C.3
-
57
-
-
77954361859
-
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma
-
Sasaki A, Kamiyama T, Yokoo H, et al. Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Oncol Rep. 2010;24:537-46.
-
(2010)
Oncol Rep.
, vol.24
, pp. 537-546
-
-
Sasaki, A.1
Kamiyama, T.2
Yokoo, H.3
-
58
-
-
77957948577
-
Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer
-
Nakamura M, Kyo S, Zhang B, et al. Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum Pathol. 2010;41:1516-29.
-
(2010)
Hum Pathol.
, vol.41
, pp. 1516-1529
-
-
Nakamura, M.1
Kyo, S.2
Zhang, B.3
-
59
-
-
79955106228
-
Prognostic value of CD133 expression in stage I lung adenocarcinomas
-
Woo T, Okudela K, Mitsui H, et al. Prognostic value of CD133 expression in stage I lung adenocarcinomas. Int J Clin Exp Pathol. 2010;4:32-42.
-
(2010)
Int J Clin Exp Pathol.
, vol.4
, pp. 32-42
-
-
Woo, T.1
Okudela, K.2
Mitsui, H.3
-
60
-
-
52449091004
-
Drug-selected human lung cancer stem cells: Cytokine network, tumorigenic and metastatic properties
-
Levina V, Marrangoni AM, DeMarco R, et al. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008;3:e3077.
-
(2008)
PLoS One.
, vol.3
-
-
Levina, V.1
Marrangoni, A.M.2
DeMarco, R.3
-
61
-
-
34848866647
-
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
-
DOI 10.1016/j.stem.2007.08.001, PII S193459090700118X
-
Todaro M, Alea MP, Di Stefano AB, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell. 2007;1:389-402. (Pubitemid 47506537)
-
(2007)
Cell Stem Cell
, vol.1
, Issue.4
, pp. 389-402
-
-
Todaro, M.1
Alea, M.P.2
Di Stefano, A.B.3
Cammareri, P.4
Vermeulen, L.5
Iovino, F.6
Tripodo, C.7
Russo, A.8
Gulotta, G.9
Medema, J.P.10
Stassi, G.11
-
62
-
-
33845317573
-
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
-
DOI 10.1038/nature05236, PII NATURE05236
-
Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756-60. (Pubitemid 44949604)
-
(2006)
Nature
, vol.444
, Issue.7120
, pp. 756-760
-
-
Bao, S.1
Wu, Q.2
McLendon, R.E.3
Hao, Y.4
Shi, Q.5
Hjelmeland, A.B.6
Dewhirst, M.W.7
Bigner, D.D.8
Rich, J.N.9
-
63
-
-
46449115281
-
Stem cell-related "selfrenewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
-
Murat A, Migliavacca E, Gorlia T, et al. Stem cell-related "selfrenewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol. 2008;26:3015-24.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 3015-3024
-
-
Murat, A.1
Migliavacca, E.2
Gorlia, T.3
-
64
-
-
71549155909
-
Correlation of CD133 OCT4 and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy
-
Saigusa S, Tanaka K, Toiyama Y, et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol. 2009;16:3488-98.
-
(2009)
Ann Surg Oncol.
, vol.16
, pp. 3488-3498
-
-
Saigusa, S.1
Tanaka, K.2
Toiyama, Y.3
-
65
-
-
79953234572
-
Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer
-
Nagata T, Sakakura C, Komiyama S, et al. Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res. 2011;31:495-500.
-
(2011)
Anticancer Res.
, vol.31
, pp. 495-500
-
-
Nagata, T.1
Sakakura, C.2
Komiyama, S.3
-
67
-
-
28644432204
-
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
-
DOI 10.1038/nature04186
-
Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature. 2005;438:820-7. (Pubitemid 41753060)
-
(2005)
Nature
, vol.438
, Issue.7069
, pp. 820-827
-
-
Kaplan, R.N.1
Riba, R.D.2
Zacharoulis, S.3
Bramley, A.H.4
Vincent, L.5
Costa, C.6
MacDonald, D.D.7
Jin, D.K.8
Shido, K.9
Kerns, S.A.10
Zhu, Z.11
Hicklin, D.12
Wu, Y.13
Port, J.L.14
Altorki, N.15
Port, E.R.16
Ruggero, D.17
Shmelkov, S.V.18
Jensen, K.K.19
Rafii, S.20
Lyden, D.21
more..
-
68
-
-
34547106802
-
Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence
-
DOI 10.1002/cncr.22774
-
Lin EH, Hassan M, Li Y, et al.: Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 2007;110:534-42. This is the first paper to describe the prognostic value of CD133 mRNA in colorectal cancer. (Pubitemid 47106141)
-
(2007)
Cancer
, vol.110
, Issue.3
, pp. 534-542
-
-
Lin, E.H.1
Hassan, M.2
Li, Y.3
Zhao, H.4
Nooka, A.5
Sorenson, E.6
Xie, K.7
Champlin, R.8
Wu, X.9
Li, D.10
-
69
-
-
33746906996
-
Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer
-
DOI 10.1158/0008-5472.CAN-05-4654
-
Dome B, Timar J, Dobos J, et al. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res. 2006;66:7341-7. (Pubitemid 44197717)
-
(2006)
Cancer Research
, vol.66
, Issue.14
, pp. 7341-7347
-
-
Dome, B.1
Timar, J.2
Dobos, J.3
Meszaros, L.4
Raso, E.5
Paku, S.6
Kenessey, I.7
Ostoros, G.8
Magyar, M.9
Ladanyi, A.10
Bogos, K.11
Tovari, J.12
-
70
-
-
33748375376
-
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases
-
DOI 10.1158/1078-0432.CCR-06-0422
-
Mehra N, Penning M, Maas J, et al. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin Cancer Res. 2006;12:4859-66. (Pubitemid 44338571)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.16
, pp. 4859-4866
-
-
Mehra, N.1
Penning, M.2
Maas, J.3
Beerepoot, L.V.4
Van Daal, N.5
Van Gils, C.H.6
Giles, R.H.7
Voest, E.E.8
-
71
-
-
79955030814
-
Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' Stage B and C colorectal cancer
-
This is the first paper to describe the role of CD133 mRNA in stage B and C colorectal cancer
-
Iinuma H, Watanabe T, Mimori K, et al.: Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' Stage B and C Colorectal Cancer. J Clin Oncol 2011. This is the first paper to describe the role of CD133 mRNA in stage B and C colorectal cancer.
-
(2011)
J Clin Oncol
-
-
Iinuma, H.1
Watanabe, T.2
Mimori, K.3
-
72
-
-
33947505827
-
Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer
-
Iinuma H, Okinaga K, Egami H, et al. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int J Oncol. 2006;28:297-306.
-
(2006)
Int J Oncol.
, vol.28
, pp. 297-306
-
-
Iinuma, H.1
Okinaga, K.2
Egami, H.3
-
73
-
-
77954269426
-
Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery
-
Nakamura K, Iinuma H, Aoyagi Y, et al. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery. Oncology. 2010;78:309-15.
-
(2010)
Oncology.
, vol.78
, pp. 309-315
-
-
Nakamura, K.1
Iinuma, H.2
Aoyagi, Y.3
-
74
-
-
74149087446
-
Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer
-
Tralhao JG, Hoti E, Serodio M, et al. Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer. Eur J Surg Oncol. 2010;36:125-9.
-
(2010)
Eur J Surg Oncol.
, vol.36
, pp. 125-129
-
-
Tralhao, J.G.1
Hoti, E.2
Serodio, M.3
-
75
-
-
75549091170
-
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients
-
Vroling L, Lind JS, de Haas RR, et al. CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients. Br J Cancer. 2010;102:268-75.
-
(2010)
Br J Cancer.
, vol.102
, pp. 268-275
-
-
Vroling, L.1
Lind, J.S.2
De Haas, R.R.3
-
76
-
-
11144354392
-
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
-
DOI 10.1038/nm988
-
Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10:145-7. (Pubitemid 38524883)
-
(2004)
Nature Medicine
, vol.10
, Issue.2
, pp. 145-147
-
-
Willett, C.G.1
Boucher, Y.2
Di Tomaso, E.3
Duda, D.G.4
Munn, L.L.5
Tong, R.T.6
Chung, D.C.7
Sahani, D.V.8
Kalva, S.P.9
Kozin, S.V.10
Mino, M.11
Cohen, K.S.12
Scadden, D.T.13
Hartford, A.C.14
Fischman, A.J.15
Clark, J.W.16
Ryan, D.P.17
Zhu, A.X.18
Blaszkowsky, L.S.19
Chen, H.X.20
Shellito, P.C.21
Lauwers, G.Y.22
Jain, R.K.23
more..
-
77
-
-
73349127099
-
Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab
-
Calleri A, Bono A, Bagnardi V, et al. Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab. Clin Cancer Res. 2009;15:7652-7.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 7652-7657
-
-
Calleri, A.1
Bono, A.2
Bagnardi, V.3
-
78
-
-
46349107401
-
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
-
DOI 10.1038/sj.bjc.6604437, PII 6604437
-
Smith LM, Nesterova A, Ryan MC, et al. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer. 2008;99:100-9. (Pubitemid 351920235)
-
(2008)
British Journal of Cancer
, vol.99
, Issue.1
, pp. 100-109
-
-
Smith, L.M.1
Nesterova, A.2
Ryan, M.C.3
Duniho, S.4
Jonas, M.5
Anderson, M.6
Zabinski, R.F.7
Sutherland, M.K.8
Gerber, H.-P.9
Van Orden, K.L.10
Moore, P.A.11
Ruben, S.M.12
Carter, P.J.13
-
79
-
-
68549107867
-
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
-
Gedye C, Quirk J, Browning J, et al. Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells. Cancer Immunol Immunother. 2009;58:1635-46.
-
(2009)
Cancer Immunol Immunother.
, vol.58
, pp. 1635-1646
-
-
Gedye, C.1
Quirk, J.2
Browning, J.3
-
80
-
-
58049201990
-
The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma
-
Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells. 2008;26:3008-17.
-
(2008)
Stem Cells.
, vol.26
, pp. 3008-3017
-
-
Rappa, G.1
Fodstad, O.2
Lorico, A.3
-
81
-
-
68749099671
-
Identification of selective inhibitors of cancer stem cells by high-throughput screening
-
Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138:645-59.
-
(2009)
Cell.
, vol.138
, pp. 645-659
-
-
Gupta, P.B.1
Onder, T.T.2
Jiang, G.3
-
82
-
-
70349638289
-
Tumour-initiating cells: Challenges and opportunities for anticancer drug discovery
-
Zhou BB, Zhang H, Damelin M, et al. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov. 2009;8:806-23.
-
(2009)
Nat Rev Drug Discov.
, vol.8
, pp. 806-823
-
-
Zhou, B.B.1
Zhang, H.2
Damelin, M.3
-
83
-
-
84856228013
-
Efficiently targeting cancer stem cells requires tactical activation from their dormant state and subsequent exhaustion
-
Lin E, He X, Yan XW, et al.: Efficiently targeting cancer stem cells requires tactical activation from their dormant state and subsequent exhaustion. Proceedings of American Association of Cancer Research 2010;LB254.
-
(2010)
Proceedings of American Association of Cancer Research
-
-
Lin, E.1
He, X.2
Yan, X.W.3
|